Intra-Cellular Therapies Inc. buy Cantor Fitzgerald
Start price
03.11.23
/
50%
€51.30
Target price
03.11.24
€94.07
Performance (%)
16.96%
Price
09:32
€59.50
Summary
This prediction is currently active. The prediction currently has a performance of 16.96%. This prediction currently runs until 03.11.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 0.833% | 0.833% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Cantor Fitzgerald from $98.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
24.04.24
24.04.24
€112.30
24.04.25
24.04.25
-13.14%
09:32
09:32
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€64.80
23.02.24
23.02.24
€93.28
23.02.25
23.02.25
-8.18%
09:32
09:32
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€59.40
14.12.23
14.12.23
€91.89
14.12.24
14.12.24
0.17%
09:32
09:32
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€80.23
29.03.24
29.03.24
22.14%
30.03.24
30.03.24